Pay in 4 interest-free payments of $5.54 Learn more
Ships within 48 hours · Estimated delivery Nov 13 - Nov 18
what are glp 1 agonist GLP-1 Receptor Services for Type 2 Diabetes and Obesity Drug Development goal-fatloss Size:120 GLP-1
GLP-1
To understand Key Opinion Leaders’ perspectives around the accessibility and acceptability of emerging treatment options along with GLP-1 agonists unmet need of current therapies Details on report methodology, top indications covered, market assumptions, patient journey and KOLs to strengthen the pharmaceutical companies’ development and launch strategy.
goal-fatloss
Size:120
He explained: “More importantly — and not related to this study — is that improving glycemic control and allowing obese patients to lose weight tends to improve patients’ mood and outlook on their disease
US$ 29.49
US$ 28.07
US$ 22.00
US$ 25.13
US$ 20.31
US$ 20.44
US$ 23.33
US$ 24.63
